Literature DB >> 34590380

Current therapeutic options for low-risk papillary thyroid carcinoma: Scoping evidence review.

Alvaro Sanabria1,2, Pilar Pinillos3, Renan B Lira4, Jatin P Shah5,6, Ralph P Tufano7, Mark E Zafereo8, Iain J Nixon9, Gregory W Randolph10, Ricard Simo11, Vincent Vander Poorten12,13, Alessandra Rinaldo14, Jesus E Medina15, Avi Khafif16, Peter Angelos17, Antti A Mäkitie18, Ashok R Shaha5, Juan P Rodrigo19,20,21, Dana M Hartl22,23, Luiz P Kowalski4,24, Alfio Ferlito25.   

Abstract

Most cases of thyroid carcinoma are classified as low risk. These lesions have been treated with open surgery, remote access thyroidectomy, active surveillance, and percutaneous ablation. However, there is lack of consensus and clear indications for a specific treatment selection. The objective of this study is to review the literature regarding the indications for management selection for low-risk carcinomas. Systematic review exploring inclusion and exclusion criteria used to select patients with low-risk carcinomas for treatment approaches. The search found 69 studies. The inclusion criteria most reported were nodule diameter and histopathological confirmation of the tumor type. The most common exclusions were lymph node metastasis and extra-thyroidal extension. There was significant heterogeneity among inclusion and exclusion criteria according to the analyzed therapeutic approach. Alternative therapeutic approaches in low-risk carcinomas can be cautiously considered. Open thyroidectomy remains the standard treatment against which all other approaches must be compared.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  ablation; papillary carcinoma; surgery; surveillance; thyroid carcinoma; treatment

Mesh:

Year:  2021        PMID: 34590380     DOI: 10.1002/hed.26883

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

Review 1.  Hypercalcemia in IgG4-related disease: coincidental or associated? Case based review.

Authors:  Döndü Üsküdar Cansu; Güven Barış Cansu; Reşit Yildirim; Mustafa Dinler; Emel Tekin; İlknur Ak Sivrikoz; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2022-01-07       Impact factor: 2.631

2.  Establishing a predictive model of hypoparathyroidism after total thyroidectomy and central lymph node dissection for postoperative calcium supplementation selectively.

Authors:  Tao Huang; Xiang Zhong; Tianyi He; Wei Zhang; Zhixian He
Journal:  Ann Transl Med       Date:  2022-06

3.  The Necessity of Lymph Node Dissection Between Sternocleidomastoid and Sternohyoid Muscles in pN1b Papillary Thyroid Carcinoma.

Authors:  Yuanpeng Zhai; Litao Ruan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-25       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.